Quantcast
Channel: メディカルプレスセンター QLifePro »その他
Browsing all 5564 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

GC Biopharma Reports Q1 2022 Results

  YONGIN, South Korea GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the...

View Article


Image may be NSFW.
Clik here to view.

Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer

  BASEL, Switzerland Alentis Therapeutics (“Alentis” or “the Company”), the biotechnology company developing breakthrough treatments for organ fibrosis and fibrotic-associated cancers, today announced...

View Article


Image may be NSFW.
Clik here to view.

CANbridge-UMass Chan Medical School Gene Therapy Research to be Presented at...

  BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., (“CANbridge,”1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and...

View Article

Image may be NSFW.
Clik here to view.

NTHU Post-Baccalaureate Program in Medicine Holds Opening Ceremony

  HSINCHU, Taiwan On March 30, NTHU held the opening ceremony for the Post-baccalaureate Program in Medicine, during which NTHU president Hocheng Hong said that the new program will train students to...

View Article

Image may be NSFW.
Clik here to view.

ENHERTU® Approved in the U.S. for Patients with HER2 Positive Metastatic...

  TOKYO & BASKING RIDGE, N.J. Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult...

View Article


Image may be NSFW.
Clik here to view.

Alentis Therapeutics任命Andrea Pellacani博士为首席医疗官

  瑞士巴塞尔 (美国商业资讯)–Alentis Therapeutics(以下简称“Alentis ”或 “该公司”)是一家针对器官纤维化和纤维化相关癌症开发突破性疗法的生物技术公司。该公司今天宣布任命Andrea Pellacani博士为首席医疗官。 本新闻稿包含多媒体。此处查看新闻稿全文:...

View Article

Image may be NSFW.
Clik here to view.

患者安全运动基金会宣布2021年度人道主义奖和刘易斯·布莱克曼奖的获奖者

  加利福尼亚州尔湾市 (美国商业资讯)–致力于在2030年之前实现零例可预防患者死亡的全球性非营利组织患者安全运动基金会(PSMF)在其世界患者安全、科学与技术峰会(WPSSTS)第八届年度会议上宣布2021年度人道主义奖和刘易斯·布莱克曼(Lewis Blackma)奖的获奖者。美国第42任总统比尔·克林顿获得Joe Kiani人道主义奖,Javier...

View Article

Image may be NSFW.
Clik here to view.

Covetrus Introduces Innovative Cloud-Based Practice Management Software for...

  EDINBURGH, Scotland Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today introduced Ascend—a powerful, cloud-based Practice Management software (PMS) built to...

View Article


Image may be NSFW.
Clik here to view.

CureApp: World’s First Medical Device Regulatory Approval of Digital...

  TOKYO CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) was notified by the Ministry of Health, Labour and Welfare on April 26, 2022 that the company had received the medical device...

View Article


Image may be NSFW.
Clik here to view.

患者安全運動財団が2021年度人道賞およびルイス・ブラックマン賞の受賞者を発表

  米カリフォルニア州アーバイン (ビジネスワイヤ) —...

View Article

Image may be NSFW.
Clik here to view.

世界で初めて低侵襲心臓ポンプImpella BTRによる患者への治療を実施

  米マサチューセッツ州ダンバース (ビジネスワイヤ) — アビオメッド(Nasdaq: ABMD)は、米国食品医薬品局(FDA)のアーリーフィージビリティスタディ(EFS)の一環として、世界で初めて患者さんがImpella BTR(Bridge-to-Recovery、心機能回復までの橋渡し)心臓ポンプによる治療に成功したことを発表します。最初の治療は、Northwestern Medicine...

View Article

Image may be NSFW.
Clik here to view.

CureApp:全球首款高血压数字治疗App获得医疗器械监管批准

  东京 (美国商业资讯)– CureApp, Inc.(总部:东京中央区;首席执行官:Kohta Satake)于2022年4月26日接到厚生劳动省通知,该公司的高血压数字治疗app已获得医疗器械监管批准。这标志着支持医生和患者的独立软件app首次在日本获得医疗器械监管批准。这也是全球首款获准治疗高血压的app。目前CureApp正在准备将该款app纳入医保,并准备在2022年将其上架。...

View Article

Image may be NSFW.
Clik here to view.

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT7104, a...

  GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study to evaluate the safety,...

View Article


Image may be NSFW.
Clik here to view.

Todo Works Targets Global Wheelchair Market With Its Special Wheelchair for...

  SIHEUNG, South Korea Todo Works Co., Ltd., a Korean startup manufacturing wheelchairs and wheelchair power aids, announced that it will expand into the global wheelchair market with its innovative...

View Article

Image may be NSFW.
Clik here to view.

HHS Develops Helmet Module Detecting Possible Hazards Using Bio-signals to...

  ULSAN, South Korea HHS Co., Ltd. (Health & Happiness System) of Korea has developed a new helmet module which uses bio-signal sensing technology for the safety of workers at industrial sites....

View Article


Image may be NSFW.
Clik here to view.

Mawi DNA Technologies推出NextSWAB™,可获得准确且可靠性更高的新冠病毒检测结果

  加州海沃德 (美国商业资讯)–专注于开发生物采样创新技术的医疗器械公司Mawi DNA Technologies...

View Article

Image may be NSFW.
Clik here to view.

マウィDNAテクノロジーズが正確でより信頼性の高いCOVID-19検査結果を実現するNextSWAB™を発売

  米カリフォルニア州ヘイワード (ビジネスワイヤ) —...

View Article


Image may be NSFW.
Clik here to view.

Propanc Biopharma Offers a Novel Way to Stop Cancer

  MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...

View Article

Image may be NSFW.
Clik here to view.

DEXLEVO First in Asia to Win BEST Injectable Award at AMWC, the World’s...

  SEOUL, South Korea The aesthetic and medical device company DEXLEVO attended the 20th AMWC (Aesthetic & Anti-aging Medicine World Congress) held in Monaco and explained its products to the...

View Article

Image may be NSFW.
Clik here to view.

Pacific Prime’s Latest Report Finds That Health Insurance Premiums Have...

  HONG KONG Based on a study of 100 locations around the world, global health insurance brokerage Pacific Prime’s latest report finds that average international private medical insurance (IPMI)...

View Article
Browsing all 5564 articles
Browse latest View live